HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) shares were down 4% during trading on Monday . The company traded as low as $100.67 and last traded at $100.59. Approximately 695,771 shares were traded during mid-day trading, a decline of 33% from the average daily volume of 1,035,082 shares. The stock had previously closed at $104.76.
Analyst Ratings Changes
Several equities research analysts recently weighed in on HQY shares. Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. JMP Securities increased their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Barrington Research lifted their price target on shares of HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Finally, The Goldman Sachs Group upped their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $118.09.
Get Our Latest Analysis on HealthEquity
HealthEquity Price Performance
The firm's fifty day simple moving average is $95.61 and its 200-day simple moving average is $97.87. The firm has a market capitalization of $8.82 billion, a PE ratio of 74.45, a PEG ratio of 1.56 and a beta of 0.49. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50.
HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same quarter in the prior year, the company posted $0.80 earnings per share. On average, research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.
Insider Transactions at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the sale, the director now owns 253,510 shares in the company, valued at $28,413,400.80. This represents a 34.61% decrease in their position. The disclosure for this sale can be found here. Insiders sold 304,581 shares of company stock worth $33,664,018 over the last quarter. 1.50% of the stock is currently owned by insiders.
Institutional Investors Weigh In On HealthEquity
A number of hedge funds have recently added to or reduced their stakes in HQY. Voya Investment Management LLC grew its holdings in shares of HealthEquity by 96.5% in the first quarter. Voya Investment Management LLC now owns 153,413 shares of the company's stock worth $13,557,000 after acquiring an additional 75,341 shares during the period. Inspire Investing LLC boosted its position in HealthEquity by 8.6% in the first quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock worth $665,000 after purchasing an additional 597 shares during the last quarter. Hodges Capital Management Inc. bought a new stake in shares of HealthEquity during the 1st quarter valued at about $1,988,000. Strs Ohio purchased a new stake in shares of HealthEquity during the 1st quarter valued at about $999,000. Finally, Mattson Financial Services LLC increased its position in shares of HealthEquity by 15.5% during the 1st quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock valued at $176,000 after purchasing an additional 267 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity Company Profile
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.